Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Glatting

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
British Journal of Haematology|August 16, 2005
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II studyMark Ringhoffer, Norbert Blumstein, Bernd Neumaier, et al.
Cancer Research|November 17, 2006
Molecular imaging of proliferation in malignant lymphomaAndreas K Buck, Martin Bommer, Stephan Stilgenbauer, et al.
Diagnostics (Basel, Switzerland)|August 29, 2024
From Phantoms to Patients: Improved Fusion and Voxel-Wise Analysis of Diffusion-Weighted Imaging and FDG-Positron Emission Tomography in Positron Emission Tomography/Magnetic Resonance Imaging for Combined Metabolic-Diffusivity Index (cDMI)Katharina Deininger, Patrick Korf, Leonard Lauber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2008
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidineAndreas K Buck, Ken Herrmann, Christian Meyer Zum Büschenfelde, et al.
Blood|February 18, 2011
Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseasesAnsgar S Schulz, Gerhard Glatting, Manfred Hoenig, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantationThorsten Zenz, Richard F Schlenk, Gerhard Glatting, et al.
Scientific Reports|October 31, 2019
Radiation-induced malignancies after intensity-modulated versus conventional mediastinal radiotherapy in a small animal modelKaga Gomarteli, Jens Fleckenstein, Stefanie Kirschner, et al.
Zeitschrift Fur Medizinische Physik|January 17, 2021
Comparison of MRI-based and PET-based image pre-processing for quantification of <sup>11</sup>C-PBB3 uptake in human brainElham Yousefzadeh-Nowshahr, Gordon Winter, Peter Bohn, et al.
Plos One|April 11, 2022
Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical settingElham Yousefzadeh-Nowshahr, Gordon Winter, Peter Bohn, et al.
Biomedicines|July 27, 2024
Exploratory Tau PET/CT with [11C]PBB3 in Patients with Suspected Alzheimer's Disease and Frontotemporal Lobar Degeneration: A Pilot Study on Correlation with PET Imaging and Cerebrospinal Fluid BiomarkersJoachim Strobel, Elham Yousefzadeh-Nowshahr, Katharina Deininger, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
British Journal of Haematology|August 16, 2005
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II studyMark Ringhoffer, Norbert Blumstein, Bernd Neumaier, et al.
Cancer Research|November 17, 2006
Molecular imaging of proliferation in malignant lymphomaAndreas K Buck, Martin Bommer, Stephan Stilgenbauer, et al.
Diagnostics (Basel, Switzerland)|August 29, 2024
From Phantoms to Patients: Improved Fusion and Voxel-Wise Analysis of Diffusion-Weighted Imaging and FDG-Positron Emission Tomography in Positron Emission Tomography/Magnetic Resonance Imaging for Combined Metabolic-Diffusivity Index (cDMI)Katharina Deininger, Patrick Korf, Leonard Lauber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2008
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidineAndreas K Buck, Ken Herrmann, Christian Meyer Zum Büschenfelde, et al.
Blood|February 18, 2011
Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseasesAnsgar S Schulz, Gerhard Glatting, Manfred Hoenig, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantationThorsten Zenz, Richard F Schlenk, Gerhard Glatting, et al.
Scientific Reports|October 31, 2019
Radiation-induced malignancies after intensity-modulated versus conventional mediastinal radiotherapy in a small animal modelKaga Gomarteli, Jens Fleckenstein, Stefanie Kirschner, et al.
Zeitschrift Fur Medizinische Physik|January 17, 2021
Comparison of MRI-based and PET-based image pre-processing for quantification of <sup>11</sup>C-PBB3 uptake in human brainElham Yousefzadeh-Nowshahr, Gordon Winter, Peter Bohn, et al.
Plos One|April 11, 2022
Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical settingElham Yousefzadeh-Nowshahr, Gordon Winter, Peter Bohn, et al.
Biomedicines|July 27, 2024
Exploratory Tau PET/CT with [11C]PBB3 in Patients with Suspected Alzheimer's Disease and Frontotemporal Lobar Degeneration: A Pilot Study on Correlation with PET Imaging and Cerebrospinal Fluid BiomarkersJoachim Strobel, Elham Yousefzadeh-Nowshahr, Katharina Deininger, et al.
Pageof 15